Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A Nonfimbrial Adhesin of Aggregatibacter actinomycetemcomitans Mediates Biofilm Biogenesis.

Danforth DR, Tang-Siegel G, Ruiz T, Mintz KP.

Infect Immun. 2018 Dec 19;87(1). pii: e00704-18. doi: 10.1128/IAI.00704-18. Print 2019 Jan.

PMID:
30297525
2.

Inner-membrane protein MorC is involved in fimbriae production and biofilm formation in Aggregatibacter actinomycetemcomitans.

Smith KP, Ruiz T, Mintz KP.

Microbiology. 2016 Mar;162(3):513-25. doi: 10.1099/mic.0.000246. Epub 2016 Jan 20.

3.

The conserved carboxyl domain of MorC, an inner membrane protein of Aggregatibacter actinomycetemcomitans, is essential for membrane function.

Smith KP, Voogt RD, Ruiz T, Mintz KP.

Mol Oral Microbiol. 2016 Feb;31(1):43-58. doi: 10.1111/omi.12120. Epub 2015 Sep 15.

4.

Alteration in abundance of specific membrane proteins of Aggregatibacter actinomycetemcomitans is attributed to deletion of the inner membrane protein MorC.

Smith KP, Fields JG, Voogt RD, Deng B, Lam YW, Mintz KP.

Proteomics. 2015 Jun;15(11):1859-67. doi: 10.1002/pmic.201400505. Epub 2015 Mar 17.

5.

The cell envelope proteome of Aggregatibacter actinomycetemcomitans.

Smith KP, Fields JG, Voogt RD, Deng B, Lam YW, Mintz KP.

Mol Oral Microbiol. 2015 Apr;30(2):97-110. doi: 10.1111/omi.12074. Epub 2014 Oct 3.

6.

Ultrastructural analysis of the rugose cell envelope of a member of the Pasteurellaceae family.

Azari F, Nyland L, Yu C, Radermacher M, Mintz KP, Ruiz T.

J Bacteriol. 2013 Apr;195(8):1680-8. doi: 10.1128/JB.02149-12. Epub 2013 Feb 1.

7.

Characterization of the secretion pathway of the collagen adhesin EmaA of Aggregatibacter actinomycetemcomitans.

Jiang X, Ruiz T, Mintz KP.

Mol Oral Microbiol. 2012 Oct;27(5):382-96. doi: 10.1111/j.2041-1014.2012.00652.x. Epub 2012 May 26.

8.

O-polysaccharide glycosylation is required for stability and function of the collagen adhesin EmaA of Aggregatibacter actinomycetemcomitans.

Tang G, Ruiz T, Mintz KP.

Infect Immun. 2012 Aug;80(8):2868-77. doi: 10.1128/IAI.00372-12. Epub 2012 Jun 11.

9.

Lipopolysaccharides mediate leukotoxin secretion in Aggregatibacter actinomycetemcomitans.

Tang G, Kawai T, Komatsuzawa H, Mintz KP.

Mol Oral Microbiol. 2012 Apr;27(2):70-82. doi: 10.1111/j.2041-1014.2011.00632.x. Epub 2011 Dec 7.

10.

Correlation of the amino-acid sequence and the 3D structure of the functional domain of EmaA from Aggregatibacter actinomycetemcomitans.

Azari F, Radermacher M, Mintz KP, Ruiz T.

J Struct Biol. 2012 Feb;177(2):439-46. doi: 10.1016/j.jsb.2011.11.024. Epub 2011 Dec 2.

11.

The extended signal peptide of the trimeric autotransporter EmaA of Aggregatibacter actinomycetemcomitans modulates secretion.

Jiang X, Ruiz T, Mintz KP.

J Bacteriol. 2011 Dec;193(24):6983-94. doi: 10.1128/JB.05813-11. Epub 2011 Oct 14.

12.
13.

Investigation of the three-dimensional architecture of the collagen adhesin EmaA of Aggregatibacter actinomycetemcomitans by electron tomography.

Yu C, Mintz KP, Ruiz T.

J Bacteriol. 2009 Oct;191(20):6253-61. doi: 10.1128/JB.00563-09. Epub 2009 Aug 28.

14.

Membrane morphology and leukotoxin secretion are associated with a novel membrane protein of Aggregatibacter actinomycetemcomitans.

Gallant CV, Sedic M, Chicoine EA, Ruiz T, Mintz KP.

J Bacteriol. 2008 Sep;190(17):5972-80. doi: 10.1128/JB.00548-08. Epub 2008 Jul 11.

15.

EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis.

Tang G, Kitten T, Munro CL, Wellman GC, Mintz KP.

Infect Immun. 2008 Jun;76(6):2316-24. doi: 10.1128/IAI.00021-08. Epub 2008 Mar 17.

16.

Functional mapping of an oligomeric autotransporter adhesin of Aggregatibacter actinomycetemcomitans.

Yu C, Ruiz T, Lenox C, Mintz KP.

J Bacteriol. 2008 May;190(9):3098-109. doi: 10.1128/JB.01709-07. Epub 2008 Feb 29.

17.

Molecular heterogeneity of EmaA, an oligomeric autotransporter adhesin of Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Tang G, Ruiz T, Barrantes-Reynolds R, Mintz KP.

Microbiology. 2007 Aug;153(Pt 8):2447-57.

PMID:
17660409
18.

Novel surface structures are associated with the adhesion of Actinobacillus actinomycetemcomitans to collagen.

Ruiz T, Lenox C, Radermacher M, Mintz KP.

Infect Immun. 2006 Nov;74(11):6163-70.

20.
21.
23.
24.

Virulence factors of Actinobacillus actinomycetemcomitans.

Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C.

Periodontol 2000. 1999 Jun;20:136-67. Review.

PMID:
10522226
25.

Binding of the periodontal pathogen Actinobacillus actinomycetemcomitans to extracellular matrix proteins.

Mintz KP, Fives-Taylor PM.

Oral Microbiol Immunol. 1999 Apr;14(2):109-16.

PMID:
10219170
26.

Isolation and characterization of Fap1, a fimbriae-associated adhesin of Streptococcus parasanguis FW213.

Wu H, Mintz KP, Ladha M, Fives-Taylor PM.

Mol Microbiol. 1998 May;28(3):487-500.

27.
28.

Models of invasion of enteric and periodontal pathogens into epithelial cells: a comparative analysis.

Meyer DH, Mintz KP, Fives-Taylor PM.

Crit Rev Oral Biol Med. 1997;8(4):389-409. Review.

PMID:
9391752
29.
30.

Adhesion of Actinobacillus actinomycetemcomitans to a human oral cell line.

Mintz KP, Fives-Taylor PM.

Infect Immun. 1994 Sep;62(9):3672-8.

31.

Chlorate-induced inhibition of tyrosine sulfation on bone sialoprotein synthesized by a rat osteoblast-like cell line (UMR 106-01 BSP).

Mintz KP, Fisher LW, Grzesik WJ, Hascall VC, Midura RJ.

J Biol Chem. 1994 Feb 18;269(7):4845-52.

32.

Interactions of matrix proteins from mineralized tissues with octacalcium phosphate.

F├╝redi-Milhofer H, Moradian-Oldak J, Weiner S, Veis A, Mintz KP, Addadi L.

Connect Tissue Res. 1994;30(4):251-64.

PMID:
7956204
33.

Structure and molecular regulation of bone matrix proteins.

Robey PG, Fedarko NS, Hefferan TE, Bianco P, Vetter UK, Grzesik W, Friedenstein A, Van der Pluijm G, Mintz KP, Young MF, et al.

J Bone Miner Res. 1993 Dec;8 Suppl 2:S483-7. Review.

PMID:
8122516
34.

Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain.

Mintz KP, Grzesik WJ, Midura RJ, Robey PG, Termine JD, Fisher LW.

J Bone Miner Res. 1993 Aug;8(8):985-95.

PMID:
8213261
35.

Osteogenesis imperfecta: changes in noncollagenous proteins in bone.

Vetter U, Fisher LW, Mintz KP, Kopp JB, Tuross N, Termine JD, Robey PG.

J Bone Miner Res. 1991 May;6(5):501-5.

PMID:
2068957
36.

Detection of procollagen biosynthesis using peptide-specific antibodies.

Mintz KP, Mann KG.

Matrix. 1990 Jul;10(3):186-99.

PMID:
1699117
37.

Glucocorticoids decrease the synthesis of type I procollagen mRNAs.

Cockayne D, Sterling KM Jr, Shull S, Mintz KP, Illeyne S, Cutroneo KR.

Biochemistry. 1986 Jun 3;25(11):3202-9.

PMID:
2425847
38.

An inhibitory monoclonal antibody to rabbit brain acetylcholinesterase. Studies on interaction with the enzyme.

Brimijoin S, Mintz KP, Prendergast FG.

Mol Pharmacol. 1985 Dec;28(6):539-45.

PMID:
4079910
40.

Human acetylcholinesterase. Immunochemical studies with monoclonal antibodies.

Brimijoin S, Mintz KP.

Biochim Biophys Acta. 1985 Apr 29;828(3):290-7.

PMID:
2580561
41.

Two-step immunoaffinity purification of acetylcholinesterase from rabbit brain.

Mintz KP, Brimijoin S.

J Neurochem. 1985 Jan;44(1):225-32.

PMID:
3964830
42.

Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.

Brimijoin S, Mintz KP.

Muscle Nerve. 1984 Nov-Dec;7(9):725-32.

PMID:
6100457
43.

Evolution of butyrylcholinesterase in higher primates: an immunochemical study.

Mintz KP, Weinshilboum RM, Brimijoin WS.

Comp Biochem Physiol C. 1984;79(1):35-7.

PMID:
6149875
44.
45.

Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase.

Brimijoin S, Mintz KP, Prendergast FG.

Biochem Pharmacol. 1983 Feb 15;32(4):699-706.

PMID:
6830632

Supplemental Content

Loading ...
Support Center